OYST
Oyster Point Pharma, Inc. Common Stock
OYST
OYST
Delisted
OYST was delisted on the 30th of December, 2022.
60 hedge funds and large institutions have $331M invested in Oyster Point Pharma, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 28 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Holders
60
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$1.4M | |
| 2 | +$1.31M | |
| 3 | +$1.3M | |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$1.28M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$700K |
Top Sellers
| 1 | -$4.19M | |
| 2 | -$2.23M | |
| 3 | -$1.48M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$1.09M |
| 5 |
Millennium Management
New York
|
-$1.06M |